Published

Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Value in Health Regional Issues
Date: 2026-03-01
Source: Crossref
DOI: 10.1016/j.vhri.2026.101605
PubMed: 41842876

Authors

Ziadi Yosr Park Taehwan

Watch author

Derived topics and classifications

psilocybin Depression Treatment-Resistant Depression Other

Citation graph

33 referenced DOIs found in stored source metadata. 3 indexed papers cite this DOI.

Open citation network

10.1192/bjp.2024.266 10.4088/jcp.20m13699 10.1002/wps.21120 10.1176/ajp.2006.163.11.1905 10.1016/j.jad.2018.06.045 10.1016/j.jad.2008.10.014 10.1016/s2215-0366(16)30065-7 10.1016/j.celrep.2018.05.022 10.1016/j.euroneuro.2023.07.011 10.1016/j.psychres.2023.115531 10.1001/jama.2016.12195 10.1177/0272989x12454941

Indexed papers citing this DOI

PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEW2026-06-24 Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World Implementation2026-06-03 Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression2026-03-01

Related papers

Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-makingInstituto Politécnico do Porto · 2026-02-27 Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis.Translational psychiatry · 2025-08-29 Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand MechanismClinicalTrials.gov · 2026-08-06 Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled TrialClinicalTrials.gov · 2026-05-01 A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in VeteransClinicalTrials.gov · 2026-08-14 A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10 A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10 Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2026-08-10